Was surprised with the sudden increase today, but still did not sell because I am waiting for another bigger news... when will China allow their citizens to travel abroad. When this will happen, nobody knows. Maybe end of this year to maybe next decade, lol!
Genting Bhd got off to a firm start on the local bourse in June after it announced the completion of clinical trials of an Alzheimer’s drug by its 20.3%-owned company, TauRx Pharmaceuticals Ltd.
Answer : No wonder go up so fast today! Damn! Sold too early!
Genting Berhad's associate, TauRx Pharmaceuticals Ltd., a leader in tau-based research in Alzheimer’s, had on 31 May 2022 unveiled initial data from the completion of the randomised portion of their pivotal Phase 3 clinical trial, LUCIDITY (NCT03446001).
This volume could be other biotech/pharma or other funds who want exposure to Alzheimer's drug but knows that Genting offer the lowest cost entry and that there are no other alternatives
It was published in 2016 by The Edge, additive value of TauRx alone at around RM3 I don't think there was any bonus or split, but definitely there were esos granted during these years Give it a discount, say RM2.50 However, that was in 2016, the drug patent could be worth differently now If the article is true, whereby the efficacy is said to be significant, it may be worth more
I'm sure there will be postings coming up soon talking about the valuation of TauRx
This QR well performance recovering Next QR2 & QR3 should be kaboom result. - Skyworld news add + - TauRX news if real and positive result coming. Sure to the Moon like Elon Musk starship haha..
Tomorrow another gap up and rally + collect by Foreign & Local Funds.
JP Morgan say RM9. So I say RM6 to RM7 no issue. So i changed my TP.
Genting TauRx Diagnostic Centre Sdn Bhd, a company established in Malaysia, and its wholly owned subsidiary GT Diagnostics (UK) Limited (collectively, "GT Diagnostics") was founded as a collaboration between Genting Berhad and TauRx Pharmaceuticals Ltd Group and is currently developing new tau biomarker and psychometric tools for people with Alzheimer's, caregivers and clinicians for early detection of Alzheimer's. GT Diagnostics currently develops readily deployable e-platform tools for home use as well-being apps, alongside professional tools for expert use to aid diagnosis and monitoring of dementias.
ADR also up now. Wonder if tomorrow still got action. Surely there will be some who chase. Don't think there has ever been an Alzheimer drug. Hope TauRx gets regulator approval soon. :)
"Our data analysis is ongoing and will be reported at a later date. We look forward to providing an update on our progress on 9th June 2022 at the 35th Global Conference of Alzheimer's Disease International.“
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
bang_miskin
1,059 posts
Posted by bang_miskin > 2022-06-01 17:52 | Report Abuse
Was surprised with the sudden increase today, but still did not sell because I am waiting for another bigger news... when will China allow their citizens to travel abroad. When this will happen, nobody knows. Maybe end of this year to maybe next decade, lol!